Literature DB >> 18175094

Propofol.

C Vanlersberghe1, F Camu.   

Abstract

The hypnotic agent propofol has pharmacokinetic characteristics that allow for rapid onset and offset of drug effect and fast elimination from the body. Elderly patients show a greater sensitivity to the hypnotic effect of propofol. The drug is extensively metabolized in the liver through the cytochrome P450 system and glucuronidation, with potential for drug interaction. Propofol does not cause significant inotropic depression at clinically relevant concentrations. But in vitro, propofol impairs isotonic relaxation of the heart and decreases free cytosolic Ca(2+) concentrations in myocardial cells. In animal models, the cardioprotective effects of propofol derive in part from its antioxidant and free radical scavenging properties. Propofol decreases cerebral blood flow and cerebral metabolic rate dose-dependently. The neuroprotective effect of propofol in animal models is attributed to its antioxidant property, the potentiation of gamma-aminobutyric acid type A (GABA(A))-mediated inhibition of synaptic transmission, and the inhibition of glutamate release. Subhypnotic doses of propofol induce sedative, amnestic, and anxiolytic effects in a dose-dependent fashion. Propofol impairs ventilation with a considerable effect on the control of ventilation and central chemoreceptor sensitivity. Propofol reduces the ventilatory response to hypercapnia and the ventilatory adaptation to hypoxia, even at subanesthetic doses. The drug potentiates hypoxic pulmonary vasoconstriction, an effect caused by inhibition of K(+) (ATP)-mediated pulmonary vasodilatation. Most of the pharmacological actions of propofol result from interaction with the GABA(A) receptor or with calcium channels. Propofol prolongs inhibitory postsynaptic currents mediated by GABA(A) receptors, indicating that its effects are associated with enhanced inhibitory synaptic transmission, but propofol also influences presynaptic mechanisms of GABAergic transmission. Propofol modulates various aspects of the host's inflammatory response. It decreases secretion of proinflammatory cytokines, alters the expression of nitric oxide, impairs monocyte and neutrophil functions, and has potent, dose-dependent radical scavenging activity similar to the endogenous antioxidant vitamin E.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175094     DOI: 10.1007/978-3-540-74806-9_11

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  33 in total

1.  Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center.

Authors:  Ruwan Kiringoda; Audrey E Thurm; Matthew E Hirschtritt; Deloris Koziol; Robert Wesley; Susan E Swedo; Naomi P O'Grady; Zenaide M N Quezado
Journal:  Arch Pediatr Adolesc Med       Date:  2010-06

2.  Review on sedation for gastrointestinal tract endoscopy in children by non-anesthesiologists.

Authors:  Rok Orel; Jernej Brecelj; Jorge Amil Dias; Claudio Romano; Fernanda Barros; Mike Thomson; Yvan Vandenplas
Journal:  World J Gastrointest Endosc       Date:  2015-07-25

3.  The impact of induction of general anesthesia and a vascular occlusion test on tissue oxygen saturation derived parameters in high-risk surgical patients.

Authors:  Celine Bernet; Olivier Desebbe; Sebastien Bordon; Charlotte Lacroix; Pascal Rosamel; Fadi Farhat; Jean-Jacques Lehot; Maxime Cannesson
Journal:  J Clin Monit Comput       Date:  2011-09-23       Impact factor: 2.502

Review 4.  Anesthetic effects of propofol in the healthy human brain: functional imaging evidence.

Authors:  Xiao-xing Song; Bu-wei Yu
Journal:  J Anesth       Date:  2014-07-24       Impact factor: 2.078

5.  [Drugs for intravenous induction of anesthesia: ketamine, midazolam and synopsis of current hypnotics].

Authors:  E Halbeck; C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2018-08       Impact factor: 1.041

6.  [Deaths from propofol abuse : Survey of institutes of forensic medicine in Germany, Austria and Switzerland].

Authors:  C Maier; J Iwunna; M Tsokos; F Mußhoff
Journal:  Anaesthesist       Date:  2017-01-13       Impact factor: 1.041

Review 7.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

8.  Pharmacodynamic analysis of target-controlled infusion of propofol in patients with hepatic insufficiency.

Authors:  Jing-Ru Pan; Jun Cai; Shao-Li Zhou; Qian-Qian Zhu; Fei Huang; Yi-Han Zhang; Xin-Jin Chi; Zi-Qing Hei
Journal:  Biomed Rep       Date:  2016-10-19

9.  Commonly used intravenous anesthetics decrease bladder contractility: An in vitro study of the effects of propofol, ketamine, and midazolam on the rat bladder.

Authors:  Canan Ceran; Arzu Pampal; Ozgur Goktas; H Kutluk Pampal; Ercument Olmez
Journal:  Indian J Urol       Date:  2010-07

10.  Azo-propofols: photochromic potentiators of GABA(A) receptors.

Authors:  Marco Stein; Simon J Middendorp; Valentina Carta; Ervin Pejo; Douglas E Raines; Stuart A Forman; Erwin Sigel; Dirk Trauner
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-11       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.